Notice: file_put_contents(): Write of 319385 bytes failed with errno=28 No space left on device in /opt/frankenphp/design.onmedianet.com/app/src/Arsae/CacheManager.php on line 36

Warning: http_response_code(): Cannot set response code - headers already sent (output started at /opt/frankenphp/design.onmedianet.com/app/src/Arsae/CacheManager.php:36) in /opt/frankenphp/design.onmedianet.com/app/src/Models/Response.php on line 17

Warning: Cannot modify header information - headers already sent by (output started at /opt/frankenphp/design.onmedianet.com/app/src/Arsae/CacheManager.php:36) in /opt/frankenphp/design.onmedianet.com/app/src/Models/Response.php on line 20
Containing Pandemic Influenza at the Source | Science
Skip to main content
Advertisement
Main content starts here

Abstract

Highly pathogenic avian influenza A (subtype H5N1) is threatening to cause a human pandemic of potentially devastating proportions. We used a stochastic influenza simulation model for rural Southeast Asia to investigate the effectiveness of targeted antiviral prophylaxis, quarantine, and pre-vaccination in containing an emerging influenza strain at the source. If the basic reproductive number (R0) was below 1.60, our simulations showed that a prepared response with targeted antivirals would have a high probability of containing the disease. In that case, an antiviral agent stockpile on the order of 100,000 to 1 million courses for treatment and prophylaxis would be sufficient. If pre-vaccination occurred, then targeted antiviral prophylaxis could be effective for containing strains with an R0 as high as 2.1. Combinations of targeted antiviral prophylaxis, pre-vaccination, and quarantine could contain strains with an R0 as high as 2.4.

Register and access this article for free

As a service to the community, this article is available for free.

Access the full article

View all access options to continue reading this article.

Supplementary Material

File (1115717s1.avi)
File (1115717s2.avi)
File (1115717s3.avi)
File (longini.som.pdf)

References and Notes

1
R. J. Webby, R. G. Webster, Science302, 1519 (2003).
2
M. Enserink, Science306, 2016 (2004).
3
K. Stohr, N. Engl. J. Med.352, 405 (2005).
4
A. S. Monto, N. Engl. J. Med.352, 323 (2005).
5
N. M. Ferguson, C. Fraser, C. A. Donnelly, A. C. Ghani, R. M. Anderson, Science304, 968 (2004).
6
K. Ungchusak et al., N. Engl. J. Med.352, 333 (2005).
7
K. Stohr, M. Esveld, Science306, 2195 (2004).
8
F. G. Hayden, Philos. Trans. R. Soc. London Ser. B356, 1877 (2001).
9
R. G. Webster, Science293, 1773 (2001).
10
G. Laver, E. Garman, Science293, 1776 (2001).
11
A. S. Monto et al., JAMA282, 31 (1999).
12
I. M. Longini, M. E. Halloran, A. Nizam, Y. Yang, Am. J. Epidemiol.159, 623 (2004).
13
National Statistical Office, Population and Housing Census 2000 (available at www.nso.go.th, accessed 19 November 2004).
14
K. Faust, B. Entwisle, R. R. Rindfuss, S. J. Walsh, Y. Sawangdee, Soc. Networks21, 311 (1999).
15
P. Guest, A. Chamraathrithirong, K. Arhavanitkul, N. Piriyathamwong, Asian Pacific Migrat. J.3, 531 (1994).
16
A. Chamraathrithirong et al., National Migration Survey of Thailand (Institute for Population and Social Research, Mahidol Univeristy, Bangkok, Thailand, 1995).
17
L. R. Elveback et al., Am. J. Epidemiol.103, 152 (1976).
18
E. D. Kilbourne, The Influenza Viruses and Influenza (Academic Press, New York, 1975).
19
L. A. Rvachev, I. M. Longini, Math. Biosci.75, 3 (1985).
20
S. Cauchemez, F. Carrat, C. Viboud, A. J. Valleron, P. Y. Boëlle, Stat. Med.23, 3469 (2004).
21
W. S. Jordan, Am. Rev. Res. Dis.83, 29 (1961).
22
I. M. Longini, E. Ackerman, L. R. Elveback, Math. Biosci.38, 141 (1978).
23
L. E. Davis, G. C. Caldwell, R. E. Lynch, R. E. Bailey, Am. J. Epidemiol.92, 240 (1970).
24
R. G. Sharrar, Bull. World Health Org.41, 361 (1969).
25
K. A. Fitzner, S. M. McGhee, A. J. Hedley, K. F. Shortridge, Hong Kong Med. J.5, 87 (1999).
26
F. G. Hayden, F. Y. Aoki, in Antimicrobial Therapy and Vaccines, V. Yu, T. Meigan, S. Barriere, Eds. (Williams and Wilkins, Baltimore, MD, 1999), pp. 1344–1365.
27
F. G. Hayden et al., N. Engl. J. Med.343, 1282 (2000).
28
R. Welliver et al., JAMA285, 748 (2001).
29
Y. Yang, I. M. Longini, M. E. Halloran, Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups (Technical Report 04-09, Department of Biostatistics, Emory University, Atlanta, GA, 22 July 2004) (available at www.sph.emory.edu/bios/tech/).
30
M. E. Halloran, I. M. Longini, C. J. Struchiner, Epidemiol. Rev. Vaccines21, 73 (1999).
31
A. N. Hill, I. M. Longini, Math. Biosci.181, 85 (2003).
32
C. E. Mills, J. M. Robins, M. Lipsitch, Nature432, 904 (2004).
33
R. Antia, R. R. Regoes, J. C. Koella, C. T. Bergstrom, Nature426, 658 (2003).
34
M. E. Halloran, I. M. Longini, D. M. Cowart, A. Nizam, Vaccine20, 3254 (2002).
35
This work was supported by National Institute of General Medical Sciences MIDAS grant U01-GM070749 and National Institute of Allergy and Infectious Diseases grant R01-AI32042. The authors thank F. Hayden, K. Stöhr, P. Glezen, A. Monto, S. Dowell, and B. Schwartz for their helpful comments.

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Neither embedded figures nor equations with special characters can be submitted, and we discourage the use of figures and equations within eLetters in general. If a figure or equation is essential, please include within the text of the eLetter a link to the figure, equation, or full text with special characters at a public repository with versioning, such as Zenodo. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

ScienceAdviser

Get Science’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily.

`; currentEntityStat = entityStat; break; case 1002: htmlView = "` + ` Access through `+entityStat.entityTitle + " " + `
`; currentEntityStat = entityStat; break; case 1003: htmlView = "` + ` Access through `+entityStat.entityTitle + " " + `
`; currentEntityStat = entityStat; break; default: htmlView = defaultHtml; break; } } $seamlessAccessWrapper.html(htmlView); }, (error) => { console.log(error); }); }); })();